• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.

作者信息

Shamchuk Angela, Doulla Manpreet, Jetha Mary

机构信息

Department of Pediatrics, University of Alberta, Edmonton, Alta.

出版信息

CMAJ. 2021 Sep 7;193(35):E1385-E1388. doi: 10.1503/cmaj.202627.

DOI:10.1503/cmaj.202627
PMID:34493565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8443299/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c73/8443299/51811bc9df3c/193e1385f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c73/8443299/965087fb3afc/193e1385f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c73/8443299/51811bc9df3c/193e1385f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c73/8443299/965087fb3afc/193e1385f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c73/8443299/51811bc9df3c/193e1385f2.jpg

相似文献

1
Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.一名17岁2型糖尿病青年中糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂使用之间的可能关联
CMAJ. 2021 Sep 7;193(35):E1385-E1388. doi: 10.1503/cmaj.202627.
2
[Not Available].[无可用内容]
CMAJ. 2021 Nov 15;193(45):E1746-E1749. doi: 10.1503/cmaj.202627-f.
3
SGLT2 Inhibitors and Euglycemic Ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂与正常血糖性酮症酸中毒
Am J Ther. 2018 Jul/Aug;25(4):e498-e500. doi: 10.1097/MJT.0000000000000587.
4
[Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation].[2型糖尿病患者因卡格列净导致严重糖尿病酮症酸中毒、急性肾损伤和脱水：非典型临床表现]
Aten Primaria. 2019 Dec;51(10):664-666. doi: 10.1016/j.aprim.2019.04.007. Epub 2019 Jul 17.
5
Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.钠-葡萄糖协同转运蛋白2抑制剂所致正常血糖性酮症酸中毒
Am J Ther. 2018 Sep/Oct;25(5):e590-e591. doi: 10.1097/MJT.0000000000000602.
6
Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病酮症酸中毒
J Diabetes. 2016 Mar;8(2):175-6. doi: 10.1111/1753-0407.12353. Epub 2015 Dec 29.
7
Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes.2型糖尿病中与卡格列净相关的糖尿病酮症酸中毒
Med Clin (Barc). 2017 Feb 23;148(4):e19-e20. doi: 10.1016/j.medcli.2016.11.016. Epub 2016 Dec 29.
8
Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.2型糖尿病患者中达格列净相关的正常血糖性糖尿病酮症酸中毒：一例报告
Medicine (Baltimore). 2020 May 22;99(21):e20228. doi: 10.1097/MD.0000000000020228.
9
Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.与使用钠-葡萄糖协同转运蛋白2抑制剂相关的正常血糖性糖尿病酮症酸中毒
CMAJ. 2018 Jun 25;190(25):E766-E768. doi: 10.1503/cmaj.171319.
10
Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者中的正常血糖性糖尿病酮症酸中毒
Can Fam Physician. 2016 Sep;62(9):722-4.

引用本文的文献

1
Clinical studies of dapagliflozin in pediatric patients: a rapid review.达格列净在儿科患者中的临床研究：快速综述。
Ann Pediatr Endocrinol Metab. 2022 Dec;27(4):265-272. doi: 10.6065/apem.2244166.083. Epub 2022 Dec 31.

本文引用的文献

1
13. Children and Adolescents: .儿童和青少年： 。
Diabetes Care. 2020 Jan;43(Suppl 1):S163-S182. doi: 10.2337/dc20-S013.
2
Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.钠-葡萄糖共转运蛋白抑制剂在 1 型糖尿病治疗中的作用及预防糖尿病酮症酸中毒的风险缓解策略：STOP DKA 方案。
Diabetes Obes Metab. 2019 Oct;21(10):2192-2202. doi: 10.1111/dom.13811. Epub 2019 Jun 30.
3
ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth.
《国际儿童青少年糖尿病学会（ISPAD）2018年临床实践共识指南：青少年2型糖尿病》
Pediatr Diabetes. 2018 Oct;19 Suppl 27:28-46. doi: 10.1111/pedi.12719.
4
Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta-analysis of randomized controlled trials.钠-葡萄糖协同转运蛋白2抑制剂作为1型糖尿病胰岛素治疗的附加疗法：随机对照试验的系统评价和荟萃分析
Diabetes Obes Metab. 2018 Jul;20(7):1755-1761. doi: 10.1111/dom.13260. Epub 2018 Mar 25.
5
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.SGLT2抑制剂相关的酮症及糖尿病酮症酸中毒：基本机制与治疗前景
Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2886. Epub 2017 Feb 23.
6
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.钠-葡萄糖协同转运蛋白2抑制剂相关糖尿病酮症酸中毒：临床综述及预防与诊断建议
Clin Ther. 2016 Dec;38(12):2654-2664.e1. doi: 10.1016/j.clinthera.2016.11.002.
7
Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.除胰岛素治疗外，钠-葡萄糖协同转运蛋白2抑制剂用于2型糖尿病管理：一项随机对照试验的荟萃分析
Diabetes Obes Metab. 2017 Jan;19(1):142-147. doi: 10.1111/dom.12785. Epub 2016 Sep 29.
8
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.正常血糖性糖尿病酮症酸中毒：SGLT2抑制剂相关的可预测、可检测且可预防的安全问题
Diabetes Care. 2015 Sep;38(9):1638-42. doi: 10.2337/dc15-1380.
9
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.正常血糖性糖尿病酮症酸中毒：钠-葡萄糖协同转运蛋白2抑制剂治疗的一种潜在并发症。
Diabetes Care. 2015 Sep;38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15.
10
Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study.加拿大儿童 2 型糖尿病、药物性糖尿病和单基因糖尿病：一项前瞻性全国监测研究。
Diabetes Care. 2010 Apr;33(4):786-91. doi: 10.2337/dc09-1013. Epub 2010 Jan 12.